Saroja Pharma Industries India Ltd vs Tanfac Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 28.15 as of 20 Mar 15:30 . The P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 yearsThe P/E Ratio of Tanfac Industries Ltd changed from 13.9 on March 2021 to 32.8 on March 2025 . This represents a CAGR of 18.73% over 5 years The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 yearsThe Market Cap of Tanfac Industries Ltd changed from ₹ 243.69 crore on March 2021 to ₹ 2891 crore on March 2025 . This represents a CAGR of 64.00% over 5 years The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tanfac Industries Ltd for the Dec '25 is ₹ 173.57 crore as compare to the Sep '25 revenue of ₹ 169.31 crore. This represent the growth of 2.52% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tanfac Industries Ltd for the Dec '25 is ₹ 26.15 crore as compare to the Sep '25 ebitda of ₹ 27.49 crore. This represent the decline of -4.87% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tanfac Industries Ltd changed from ₹ 11.29 crore to ₹ 15.57 crore over 7 quarters. This represents a CAGR of 20.16% The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tanfac Industries Ltd changed from 16.86 % on March 2022 to 10.19 % on March 2025 . This represents a CAGR of -11.83% over 4 years .

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

About Tanfac Industries Ltd

Tanfac Industries Limited, is a Joint Venture Company promoted by Anupam Rasayan India Limited, previously by Aditya Birla Group and the Tamil Nadu Industrial Development Corporation Limited (TIDCO).
Incorporated in 1972, the Company is India's largest supplier of fluorine chemicals.
The Company commenced production in March 1985 with 100% capacity utilisation. The company's diversification scheme for the manufacture of Organo Fluorine Chemicals was completed in 1998-99.
The Organo Fluorine Chemicals viz. 2,4, Dichloro fluorobenzene, Acetophenone etc., used as intermediate chemicals in the manufacture of new generation antibiotics (bulk drugs) called Ciprofloxacin, Enrofloxacin etc.
The technology was sourced from Dalian F Chem, China. In 2000-01 the operations of the Company's new project for manufacture of DFCA remained suspended as it is uneconomical to operate the plant at the current depressed market price.

FAQs for the comparison of Saroja Pharma Industries India Ltd and Tanfac Industries Ltd

Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or Tanfac Industries Ltd?

Market cap of Saroja Pharma Industries India Ltd is 11 Cr while Market cap of Tanfac Industries Ltd is 3,871 Cr

What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and Tanfac Industries Ltd?

The stock performance of Saroja Pharma Industries India Ltd and Tanfac Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Saroja Pharma Industries India Ltd and Tanfac Industries Ltd?

As of March 22, 2026, the Saroja Pharma Industries India Ltd stock price is INR ₹28.15. On the other hand, Tanfac Industries Ltd stock price is INR ₹1940.8.

How do dividend payouts of Saroja Pharma Industries India Ltd and Tanfac Industries Ltd compare?

To compare the dividend payouts of Saroja Pharma Industries India Ltd and Tanfac Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.